Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a behavioral healthcare company that operates a large network of inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, comprehensive treatment centers and outpatient clinics across the United States and Puerto Rico. This news page aggregates company-specific updates and disclosures that help investors and observers follow developments in Acadia’s behavioral healthcare operations and corporate activities.
News related to ACHC often includes quarterly earnings releases, updates to financial guidance, and details on revenue performance by service type, such as acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers and residential treatment centers. The company also issues news about capital expenditure plans, bed additions, and development activity, including the opening of new hospitals, expansions of existing facilities and the addition of new comprehensive treatment centers.
Acadia’s news flow features announcements about participation in healthcare and investor conferences hosted by firms such as J.P. Morgan, UBS and Jefferies, where members of senior management discuss strategy, capital allocation and operating performance. Press releases may also cover executive leadership changes, including appointments and transitions in key roles like the Chief Financial Officer and Chief Operating Officer, as well as statements from the company regarding its approach to shareholder value and governance.
Other notable news items can include updates on professional and general liability reserves, securities litigation settlements, and responses to public letters from shareholders who comment on strategy and governance. By reviewing the ACHC news feed on this page, users can monitor Acadia’s reported operating trends, strategic priorities, capital plans and governance developments over time.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Acadia Healthcare Company (NASDAQ: ACHC) reported strong financial results for Q1 2023, with revenue of $704.3 million, reflecting a 14.2% increase compared to Q1 2022. Net income was $66.0 million or $0.72 per diluted share, with adjusted EBITDA of $151.3 million, an 11.6% increase year-over-year. The company is expanding its facilities, adding 106 beds in Q1 and targeting approximately 300 beds for the year. Acadia anticipates opening four new inpatient facilities and six comprehensive treatment centers in 2023. With a strong financial position, including $63.8 million in cash and $485 million available under its credit facility, Acadia reaffirmed its guidance for 2023, projecting revenue between $2.82 to $2.88 billion and adjusted EBITDA of $635 to $675 million.
Acadia Healthcare Company (NASDAQ: ACHC) will publish its first-quarter 2023 results on April 26, 2023, after market close. A conference call for analysts is scheduled for April 27, 2023, at 9:00 a.m. ET. Acadia operates 250 facilities with around 11,000 beds across 39 states and Puerto Rico, serving over 75,000 patients daily. Employing 23,000 staff, it stands as the largest standalone behavioral healthcare provider in the U.S.
The live broadcast of the conference call will be accessible on their website for 30 days.
Geisinger and Acadia Healthcare have appointed Kelly Ankenbrand as CEO of the new Geisinger Behavioral Health Center Northeast in Moosic, Pennsylvania, effective March 6. Ankenbrand succeeds Jenna Pacini, who will lead another Acadia hospital. This 96-bed facility aims to address the mental health care needs of the community, highlighted by the fact that 1 in 5 U.S. adults experience mental illness yearly. The hospitals, supported by a joint venture, are set to enhance inpatient behavioral health services in Pennsylvania, with a second facility planned in Danville.